drugset / Trial / NCT06141590

A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions

NCT06141590 ↗

Phase 1 Completed 35 enrolled Korea United Pharm. Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This study was open-label, randomized, fed, single-dose, 2-groups, 2 periods, crossover designe to compare the safety and pharmacokinetics of UI068 and co-administration of UIC202205 and UIC202206.

Timeline

Start
2023-03-11
Primary completion
2023-08-29
Completion
2023-08-29

Drugs

EvaluationDrugModalityDoseRoute
Subject UI068 Unknown — —
Subject UIC202205 Unknown — —
Subject UIC202206 Unknown — —